title: [Clinical and experimental study on retardation of immunosenescence by kidney tonifying principle].
abstract: OBJECTIVE
  To observe the clinical curative effect of Kidney tonifying method on retardation of immunosenescence and corresponding experimental study.
  
  
  METHODS
  A randomized double blind placebo-controlled trial was used (RCT) on 22 pairs of aged subjects to elucidate the effect of Kidney tonifying recipe on the peripheral T-lymphocyte apoptosis and the Fas/FasL gene expression in them. In rats experimental study, the effects of two kinds of Chinese recipes (Kidney tonifying recipe and blood circulation promoting recipe) on the same parameters as in clinical study as well as on cell apoptosis and gene expression regulation in old rats were also observed.
  
  
  RESULTS
  Clinical study showed that after treatment, the percentage of T-lymphocyte apoptosis and the FasL gene expression in the Kidney tonifying group of aged subjects were lower than those in the placebo group (P < 0.01). Animal experiment showed the same result as shown in clinical study in Kidney tonifying recipe treated rats, but not shown in those treated with blood circulation promoting recipe statistically.
  
  
  CONCLUSIONS
  Kidney tonifying principle has down-regulating effect on the transcription of apoptotic gene in both aged persons and old rats, this is one of the molecular mechanisms of Kidney tonifying method in decreasing over-apoptosis in aged subjects and old rats.
authors.affiliation: Institute of Integrated Traditional Chinese and Western Medicine, Medical Center of Fudan University, Shanghai 200040.
authors.forename: Zi-yin
authors.initials: ZY
authors.lastname: Shen
authors.forename: Zhen
authors.initials: Z
authors.lastname: Zheng
authors.forename: Wei-min
authors.initials: WM
authors.lastname: Guo
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D000375:Aging / Q000187:drug effects*; D000818:Animals; D017209:Apoptosis / Q000187:drug effects*; D004311:Double-Blind Method; D004365:Drugs, Chinese Herbal / Q000494:pharmacology / Q000627:therapeutic use*; D053222:Fas Ligand Protein; D005260:Female; D006801:Humans; D008297:Male; D008516:Medicine, Chinese Traditional; D008562:Membrane Glycoproteins / Q000096:biosynthesis / Q000235:genetics; D008875:Middle Aged; D012333:RNA, Messenger / Q000096:biosynthesis / Q000235:genetics; D051381:Rats; D017207:Rats, Sprague-Dawley; D013601:T-Lymphocytes / Q000166:cytology*; D019014:fas Receptor / Q000096:biosynthesis / Q000235:genetics
chemical_list: D004365:Drugs, Chinese Herbal; C505661:FASLG protein, human; D053222:Fas Ligand Protein; C505662:Faslg protein, rat; D008562:Membrane Glycoproteins; D012333:RNA, Messenger; D019014:fas Receptor